FDA Aims To Speed Reviews Of New, Low-Risk Devices
The U.S. Food and Drug Administration on Friday released a draft guidance meant to streamline the process for reviews of innovative, low- or moderate-risk medical devices, which the agency says has...To view the full article, register now.
Already a subscriber? Click here to view full article